Fundamentals of Radiation Oncology (FORO) Module 1: Overview and Introduction of Radiation Basics

---

ONLINE

Friday, June 21, 2024, 12:00 AM - Sunday, June 21, 2026, 11:59 PM


ANCC - Nursing Contact Hour(s) (2.50 hours)

In module 1 of this activity series, the learners will be able to understand the history of radiation therapy, radiation treatment modalities, and important concepts related to radiation safety. The Fundamentals of Radiation Oncology educational series is an interprofessional learner-paced activity that will enhance the learners knowledge of radiation oncology and safety precautions.

1. Describe the differences between radiation treatment planning techniques and delivery methods.
2. Discuss concepts related to radiobiology and principles of radiation sensitivity.
3. Understand important principles of radiation safety.

In support of improving patient care, The University of Texas MD Anderson Cancer Center is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

The University of Texas MD Anderson Cancer Center designates this enduring material will award 2.5 Nursing Contact Hours.

View the accessibility policy for The University of Texas M.D Anderson Cancer Center.

 

The University of Texas MD Anderson Cancer Center complies with all requirements of the identified accrediting body  (ACCME, ANCC, ACPE). Disclosure of speakers, faculty members, planning committee members and their commercial relationships will be shared with learners prior to the educational activity.

Mitigation of Relevant Financial Relationships

The University of Texas MD Anderson Cancer Center adheres to the ACCME's Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CE activity, including faculty, planners, reviewers or others are required to disclose all financial relationships with ineligible companies (commercial interests). All relevant conflicts of interest have been mitigated prior to the commencement of the activity.